HomeKRON • NASDAQ
add
Kronos Bio Inc
Previous close
$0.97
Day range
$0.69 - $0.95
Year range
$0.69 - $2.29
Market cap
45.41M USD
Avg Volume
466.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 2.52M | 106.39% |
Operating expense | 21.73M | -26.88% |
Net income | -29.96M | -14.18% |
Net profit margin | -1.19K | 44.68% |
Earnings per share | — | — |
EBITDA | -18.73M | 32.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 151.98M | -32.87% |
Total assets | 182.98M | -36.69% |
Total liabilities | 46.01M | -27.45% |
Total equity | 136.97M | — |
Shares outstanding | 60.09M | — |
Price to book | 0.43 | — |
Return on assets | -24.24% | — |
Return on capital | -27.30% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -29.96M | -14.18% |
Cash from operations | -23.90M | -301.87% |
Cash from investing | 5.77M | 190.79% |
Cash from financing | — | — |
Net change in cash | -18.13M | -47.37% |
Free cash flow | -17.92M | -141.32% |
About
Founded
2017
Headquarters
Website
Employees
61